Clinical Trial Update: A Phase I/II Study of ODX (Osteodex) in Metastatic Castration Resistant Prostate Cancer (CRPC) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update shows completion of a Phase I/II study of ODX (Osteodex) in metastatic castration-resistant prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• ODX (OsteoDex)

Snippet

Sponsor: DexTech Medical AB | Conditions: Prostate Cancer Metastatic | Phase 1, Phase 2 | Status: COMPLETED